Description

BRIVASIGN 50 TAB is a prescription antiepileptic drug formulated with Brivaracetam 50mg, indicated for the treatment of partial-onset seizures in patients aged 16 years and older with epilepsy. Brivaracetam is a high-affinity ligand of synaptic vesicle protein 2A (SV2A), which helps regulate neurotransmitter release in the brain and stabilizes electrical activity.

Key therapeutic benefits:

• Effective in managing partial-onset seizures with or without secondary generalization

• Can be used as monotherapy or adjunctive therapy with other antiepileptic drugs

• Offers rapid brain penetration and better tolerability compared to some older antiepileptics

• May cause fewer behavioral side effects compared to similar medications (e.g., Levetiracetam)

BRIVASIGN 50 TAB is typically administered twice daily and dosage may be adjusted based on therapeutic response and tolerability. It is well-suited for long-term seizure control with a lower risk of interaction with other medications.

Manufactured in WHO-GMP and ISO-certified facilities, BRIVASIGN 50 TAB is proudly represented by BLUEPILL EXPRESS, a global exporter of all types of pharmaceutical medicines. With exports to Europe, North America, Asia, Africa, and the Middle East, BLUEPILL EXPRESS ensures reliable quality, timely delivery, and full regulatory support for global clients.